Shenzhen Bioeasy Biotechnology Co Ltd Class A 300942
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 7.59
- Day Range
- CNY 7.64–8.01
- 52-Week Range
- CNY 5.25–16.88
- Bid/Ask
- CNY 7.91 / CNY 7.93
- Market Cap
- CNY 3.17 Bil
- Volume/Avg
- 3.6 Mil / 7.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 12.90
- Dividend Yield (Trailing)
- 0.28%
- Dividend Yield (Forward)
- 0.28%
- Total Yield
- 0.28%
Company Profile
Shenzhen Bioeasy Biotechnology Co Ltd is dedicated towards food and drug safety, clinical diagnosis, public safety and other fields. It produces and sells clinical diagnosis products. It develops testing products for nine areas closely related to people's lives which include food safety, agricultural product safety, dairy product safety, meat safety, aquatic product safety, honey safety, clinical diagnosis, drug safety, and public safety.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 635
- Website
- http://www.bioeasy.com
Comparables
Valuation
|
Metric
|
300942
|
688253
|
688193
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 20.80 | 68.83 |
Price/Book Value | 3.61 | 2.48 | 1.32 |
Price/Sales | 12.90 | 7.93 | 7.41 |
Price/Cash Flow | 113.37 | 12.01 | 40.04 |
Price/Earnings
300942
688253
688193
Financial Strength
|
Metric
|
300942
|
688253
|
688193
|
|---|---|---|---|
Quick Ratio | — | 10.60 | 9.67 |
Current Ratio | — | 11.04 | 12.23 |
Interest Coverage | — | 1,693.02 | 22.71 |
Quick Ratio
300942
688253
688193
Profitability
|
Metric
|
300942
|
688253
|
688193
|
|---|---|---|---|
Return on Assets (Normalized) | −9.12% | 4.47% | 1.74% |
Return on Equity (Normalized) | −13.47% | 4.81% | 1.92% |
Return on Invested Capital (Normalized) | −9.72% | 4.51% | 1.35% |
Return on Assets
300942
688253
688193
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Jfcrthsy | Pctr | $545.9 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Qbnjyfhk | Sbphpm | $105.4 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Ccgjglnc | Dtdmpn | $103.7 Bil | |
MRNA
| Moderna Inc | Wqcxkpfw | Ynygc | $47.9 Bil | |
ARGX
| argenx SE ADR | Gzrbtww | Ryff | $22.9 Bil | |
BNTX
| BioNTech SE ADR | Shxlchhkz | Chsv | $22.3 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Whkyjcrz | Fcmqqm | $19.3 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Ttjdxnx | Ntmbmdk | $15.7 Bil | |
RPRX
| Royalty Pharma PLC Class A | Ndlnqbnsl | Ynmwr | $12.8 Bil | |
INCY
| Incyte Corp | Qgnjwtpg | Vscsd | $12.1 Bil |